Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.
![](https://geneocapitalentrepreneur.com/wp-content/uploads/2024/07/Format-Actualites-2-760x500.png)
Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.
Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.
Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.
GENEO Capital Entrepreneur acquires a stake in ACS - Assurances voyage & expatriation, to support the group's growth and the evolution of its governance.
GENEO Capital Entrepreneur and SIPAREX Mezzanine support Egis in its external growth and impact plan through the issue of Relance Bonds.
Founded in France nearly 100 years ago, Egis is an international group operating in the fields of consulting, construction engineering, mobility and sustainability.
Nicolas Lapeyre joins GENEO Capital Entrepreneur as Director of Development. In this role, he will be responsible for pursuing and amplifying the growth of GENEO Capital Entrepreneur, which, after almost five years in existence, now has over €550 million under management through its 3 investment vehicles dedicated to SMEs.
On the occasion of its 30th anniversary, the KARDHAM Group, France's leading independent and integrated player in professional real estate, announces that GENEO Capital Entrepreneur and Bpifrance are strengthening their presence in Kardham's capital, having been present alongside management since 2020 and 2016 respectively.
Otego, world leader in technical textiles, launches its marketplace to rethink industrial protection.
The Epiktet group, leader in home childcare with Kinougarde, continues its growth dynamic with the acquisition of Mômji, a specialist in English-speaking and creative childcare.
GENEO Capital Entrepreneur's Mission Committee held its first official meeting today, marking another concrete step in the transformation of GENEO into a mission-driven company, effective May 19, 2023. This committee will be responsible for monitoring the execution of the mission and the strategic and operational implementation of GENEO's raison d'être: "to provide the real economy with positive finance that reconciles performance and meaning".